Medtronic plc (ETR:2M6)

Market Cap	111.70B
Revenue (ttm)	29.88B
Net Income (ttm)	4.10B
Shares Out	n/a
EPS (ttm)	3.17
PE Ratio	27.27
Forward PE	17.26
Dividend	2.54 (2.88%)
Ex-Dividend Date	Sep 26, 2025

Volume	1,311
Average Volume	2,159
Open	87.62
Previous Close	87.71
Day's Range	87.18 - 88.30
52-Week Range	70.58 - 91.50
Beta	0.74
RSI	58.83
Earnings Date	Nov 18, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 2M6

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD